Your browser doesn't support javascript.
loading
Pathologic response to neoadjuvant chemotherapy in ovarian cancer and its association with outcome: A surrogate marker of survival.
Marsh, Leah A; Kim, Teresa H; Zhang, Mingyan; Kubalanza, Kari; Treece, Charisse Liz; Chase, Dana; Memarzadeh, Sanaz; Salani, Ritu; Karlan, Beth; Rao, Jianyu; Konecny, Gottfried E.
Affiliation
  • Marsh LA; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of California Los Angeles, Los Angeles, CA, USA. Electronic address: leahamarsh@gmail.com.
  • Kim TH; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, USA.
  • Zhang M; Department of Epidemiology, UCLA Fielding School of Public Health, USA.
  • Kubalanza K; Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, USA.
  • Treece CL; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, USA.
  • Chase D; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of California Los Angeles, Los Angeles, CA, USA.
  • Memarzadeh S; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of California Los Angeles, Los Angeles, CA, USA; Molecular Biology Institute, University of California, Los Angeles, CA 90095, USA; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, Unive
  • Salani R; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of California Los Angeles, Los Angeles, CA, USA.
  • Karlan B; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of California Los Angeles, Los Angeles, CA, USA.
  • Rao J; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, USA.
  • Konecny GE; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of California Los Angeles, Los Angeles, CA, USA; Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, USA.
Gynecol Oncol ; 177: 173-179, 2023 Oct.
Article in En | MEDLINE | ID: mdl-37716223
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Gynecol Oncol Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Gynecol Oncol Year: 2023 Type: Article